Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Diabetes, Metabolic Syndrome And Cardiovascular Disease

Table 6.1: Value Market Shares of Animal, Human and Modern Insulin, 1995-2010 101

Table 6.2: Worldwide Insulin Sales, 2008-2016 102

Table 6.3: Worldwide Insulin Sales and Market Share by World Region, 2011 102

Table 6.4: Estimated U.S. Retail Insulin Sales, 2011-2016 102

Table 6.5: Worldwide Insulin Sales and Market Share by Company, 2011 103

Table 6.6: U.S. Insulin Sales and Market Share by Company, 2011 103

Table 6.7: Insulins on the U.S. Market 105

Table 6.8: Pharmacokinetics of Therapeutic Insulins on the U.S. Market 106

Table 6.9: Pharmacokinetics of Short-Acting Insulins 108

Table 6.10: Pharmacokinetics of Rapid-Acting Insulins 108

Table 6.11: Pharmacokinetics of Intermediate-Acting Insulins 110

Table 6.12: Pharmacokinetics of Long-Acting Insulins 110

Table 6.13: Pharmacokinetics of Insulin Mixtures 112

Table 6.14: Status of Inhaled Insulin Products, 2011 117

Table 6.15: Key Drivers of the Type 2 Diabetes Insulin Market, 2012 122

Table 6.16: A Comparison of Existing Insulin Delivery Devices 123

Table 6.17: Insulin Pens 125

Table 6.18: Estimated Worldwide Demand for Insulin Injector Pens by Volume, 2012-2016 127

Table 6.19: Injection Aids 128

Table 6.20: Jet Injectors 130

Table 6.21: Control Averages by Treatment 131

Table 6.22: Reduced Risk for Various Diseases When Blood Glucose is Near Normal 131

Table 6.23: Leading Insulin Pump Manufacturers 132

Table 6.24: Comparison of Current External Insulin Pumps on the Market 132

Table 6.25: Insulin Infusion Sets 137

Table 6.26: Worldwide Insulin Pump Market, 2009-2016 141

Table 7.1: Advantages and Disadvantages of Newer Type 2 Diabetes Therapies 146

Table 7.2: Cells of the Pancreas 148

Table 7.3: Lipoprotein Risk Levels and Treatment Goals in Adult Patients with Diabetes 154

Table 7.4: Agents for Lowering Lipid Levels in Patients with Dyslipidemia 155

Table 7.5: Suggested Pharmacological Treatment Agents for Hypertension in Patients with Diabetes 156

Table 8.1: Criteria for the Diagnosis of Diabetes 159

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,335.28 -19.12 -0.12%
NASDAQ 3,496.43 -2.54 -0.07%
S&P 500 1,666.29 -1.18 -0.07%
US 10 Yr 1.965% +0.016

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs